Suppr超能文献

尿道重建术后长期围手术期抗生素预防并不能改善临床结局,反而会增加 MDR 病原体的发生率。

Long-term perioperative antibiotic prophylaxis after urethral reconstruction does not improve clinical outcomes and increases incidence of MDR organisms.

机构信息

University of Oklahoma College of Medicine, Oklahoma City, Oklahoma, USA.

Department of Urology, University of Oklahoma Health Sciences Center, 920 Stanton L. Young Blvd, WP 2140, Oklahoma City, Oklahoma, 73104, USA.

出版信息

World J Urol. 2024 Nov 26;42(1):648. doi: 10.1007/s00345-024-05358-7.

Abstract

PURPOSE

To analyze the impact of long-term postoperative antibiotic prophylaxis following urethral reconstruction on perioperative outcomes, postoperative urine cultures, and the emergence of multidrug-resistant bacteria.

METHODS

In this retrospective review of patients undergoing urethral reconstruction with a single surgeon from 2019 to 2023, patients either received long-term prophylactic postoperative antibiotics for 3-4 weeks while indwelling catheters were in place or they did not receive prophylactic antibiotics. Preoperative and postoperative urine cultures were obtained on all patients. The primary outcome measure was the association of prophylactic antibiotics with the presence of multidrug-resistant bacteria in postoperative urine cultures. Secondary outcomes included differences in perioperative outcomes.

RESULTS

Of 166 patients undergoing urethral reconstruction, 147 met all inclusion criteria. Of these, 84 received antibiotic prophylaxis and 63 did not. The number of multidrug-resistant organisms in postoperative urine cultures was significantly different between cohorts indicating a harmful effect of antibiotic prophylaxis (P <.01). There were no significant differences in perioperative outcomes including positive urine cultures, clinical urinary tract infections, wound complications, or recurrence.

CONCLUSION

These data show that the administration of postoperative prophylactic antibiotics does not influence perioperative outcomes but does heighten the risk of encountering multidrug-resistant bacteria. This novel finding should discourage the routine use of antibiotic prophylaxis in patients undergoing urethral reconstruction.

摘要

目的

分析尿道重建术后长期使用抗生素预防治疗对围手术期结局、术后尿培养和多重耐药菌出现的影响。

方法

本研究回顾性分析了 2019 年至 2023 年间由同一位外科医生进行尿道重建的患者,患者在留置导尿管期间接受或不接受长期预防性术后抗生素治疗 3-4 周。所有患者均进行术前和术后尿培养。主要观察指标为预防性抗生素与术后尿培养中出现多重耐药菌的相关性。次要观察指标包括围手术期结局的差异。

结果

在 166 例行尿道重建的患者中,147 例符合所有纳入标准。其中 84 例接受抗生素预防治疗,63 例未接受。术后尿培养中多重耐药菌的数量在两组之间存在显著差异,表明抗生素预防治疗具有有害作用(P<0.01)。两组之间的围手术期结局(包括阳性尿培养、临床尿路感染、伤口并发症或复发)均无显著差异。

结论

这些数据表明,术后预防性使用抗生素并不会影响围手术期结局,但会增加遇到多重耐药菌的风险。这一新发现应劝阻常规在尿道重建患者中使用抗生素预防治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ace/11599632/b2c7f0804f8f/345_2024_5358_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验